Soos J M, Ashley T A, Morrow J, Patarroyo J C, Szente B E, Zamvil S S
Center for Neurologic Diseases, Harvard Institutes of Medicine, Boston, MA 02115, USA.
Int Immunol. 1999 Jul;11(7):1169-79. doi: 10.1093/intimm/11.7.1169.
Whether astrocytes utilize B7:CD28 co-stimulation to activate T cells mediating CNS inflammatory disease is controversial. In this report, primary astrocytes and murine astrocyte lines, generated by immortalization at two different times, day 7 or 45 of culture, were examined for their capability to express B7 co-stimulatory molecules and to participate in B7:CD28 co-stimulation. Following exposure to IFN-gamma, primary astrocytes and astrocyte lines up-regulated MHC class II and B7-2 (CD86) molecules. However, B7-1 (CD80) expression was not inducible on primary astrocytes examined after IFN-gamma stimulation beginning on day 7 or on astrocyte lines immortalized on day 7. B7-1 expression was inducible on primary astrocytes examined later and could be up-regulated on astrocyte lines immortalized later. Unlike B7-1, temporal discordant expression of other co-stimulatory/adhesion molecules was not observed. Both B7-1(-)/B7-2(+) and B7-1(+)/B7-2(+) astrocyte lines were capable of stimulating proliferation of encephalitogenic Th1 cells, utilizing B7-2 for B7:CD28 co-stimulation. However, lines derived from immortalization later (B7-1(+)/B7-2(+)) were more effective in stimulating proliferation of naive myelin basic protein-specific CD4(+) T cells. Astrocyte lines that expressed both B7-1 and B7-2 also stimulated Thp cells to secrete proinflammatory Th1 cytokines, whereas lines that expressed B7-2 only stimulated Thp cells to produce a Th2 cytokine pattern. Thus, we demonstrate for the first time that individual astrocytes can differentially express B7-1 molecules, which may correlate with their ability to stimulate proinflammatory and regulatory patterns of cytokine production. These results suggest that astrocytes have potential for both promoting and down-regulating T cell responses, and that temporal differences in expression of B7 molecules should be considered when evaluating immune regulation by astrocytes.
星形胶质细胞是否利用B7:CD28共刺激来激活介导中枢神经系统炎症性疾病的T细胞仍存在争议。在本报告中,研究了原代星形胶质细胞和在培养的第7天或第45天通过永生化产生的小鼠星形胶质细胞系表达B7共刺激分子和参与B7:CD28共刺激的能力。暴露于γ干扰素后,原代星形胶质细胞和星形胶质细胞系上调了II类主要组织相容性复合体和B7-2(CD86)分子。然而,在第7天开始接受γ干扰素刺激后检测的原代星形胶质细胞或在第7天永生化的星形胶质细胞系上,B7-1(CD80)表达不可诱导。B7-1表达在稍后检测的原代星形胶质细胞上可诱导,并且在稍后永生化的星形胶质细胞系上可上调。与B7-1不同,未观察到其他共刺激/黏附分子的时间不一致表达。B7-1(-)/B7-2(+)和B7-1(+)/B7-2(+)星形胶质细胞系都能够利用B7-2进行B7:CD28共刺激,从而刺激致脑炎性Th1细胞的增殖。然而,后来永生化的细胞系(B7-1(+)/B7-2(+))在刺激幼稚的髓鞘碱性蛋白特异性CD4(+) T细胞增殖方面更有效。同时表达B7-1和B7-2的星形胶质细胞系也刺激Thp细胞分泌促炎性Th1细胞因子,而仅表达B7-2的细胞系刺激Thp细胞产生Th2细胞因子模式。因此,我们首次证明单个星形胶质细胞可以差异表达B7-1分子,这可能与其刺激炎性细胞因子产生和调节细胞因子产生模式的能力相关。这些结果表明星形胶质细胞具有促进和下调T细胞反应的潜力,并且在评估星形胶质细胞的免疫调节时应考虑B7分子表达的时间差异。